MSD has been pioneering medical progress for more than 125 years. During this time, we have been able to significantly improve treatment of numerous serious and chronic diseases. In the past 50 years alone, MSD has brought 40 new medicines onto the market - many of them representing a new class of active ingredients.

The field of vaccines is part of MSD's history. For over 100 years, we have been developing vaccines that help protect the lives of millions of people. They contribute to the fact that highly infectious diseases, such as rubella, are rare diseases today and certain HPV-related diseases can be prevented.

Learn more


MSD in Belgium

The first Belgian subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA was founded in Brussels in 1965. The global merger between MSD and Shering-Plough was in 2009 and since that time, the company has strong local roots. Our production and packaging site in the Flanders at Heist-op-den Berg has been operational since 1973 and is an important employer in the region.

Today, MSD employes more than 69.000 people worldwide in over 140 countries (as of 2017) and is one of the world’s leading research-based biopharmaceutical companies. In Belgium and Luxembourg, 1220 empoyees work at four different locations (as of 01/19).